Advertisement
Singapore markets open in 3 hours 57 minutes
  • Straits Times Index

    3,332.80
    -10.55 (-0.32%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • Dow

    39,118.86
    -45.24 (-0.12%)
     
  • Nasdaq

    17,732.60
    -126.10 (-0.71%)
     
  • Bitcoin USD

    61,914.07
    +973.35 (+1.60%)
     
  • CMC Crypto 200

    1,287.69
    +3.86 (+0.30%)
     
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • Gold

    2,336.90
    -2.70 (-0.12%)
     
  • Crude Oil

    81.46
    -0.08 (-0.10%)
     
  • 10-Yr Bond

    4.3430
    +0.0550 (+1.28%)
     
  • Nikkei

    39,583.08
    +241.58 (+0.61%)
     
  • Hang Seng

    17,718.61
    +2.11 (+0.01%)
     
  • FTSE Bursa Malaysia

    1,590.09
    +5.15 (+0.32%)
     
  • Jakarta Composite Index

    7,063.58
    -6,967.95 (-49.66%)
     
  • PSE Index

    6,411.91
    +21.33 (+0.33%)
     

It's Not Just a Bad Day for Chip Stocks. ResMed Is the S&P 500’s Top Decliner.

It's Not Just a Bad Day for Chip Stocks. ResMed Is the S&P 500’s Top Decliner.

ResMed stock was the worst performer in the S&P 500 Monday as Eli Lilly’s weight-loss medicine showed signs of reducing sleep apnea. Lilly said its medication tirzepatide, sold under the brand names Mounjaro and Zepbound, reduced obstructive sleep apnea severity by up to 62.8%. ResMed sells CPAP machines that treat sleep apnea, so this news was not a good sign for investors.